- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To demonstrate efficacy of degarelix in achieving and maintaining testosterone suppression at castrate levels (≤0.5 ng/mL) during one year of treatment in prostate cancer patients.
Critère d'inclusion
- Prostate cancer